These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

261 related articles for article (PubMed ID: 28165461)

  • 1. Structure of the homodimeric androgen receptor ligand-binding domain.
    Nadal M; Prekovic S; Gallastegui N; Helsen C; Abella M; Zielinska K; Gay M; Vilaseca M; Taulès M; Houtsmuller AB; van Royen ME; Claessens F; Fuentes-Prior P; Estébanez-Perpiñá E
    Nat Commun; 2017 Feb; 8():14388. PubMed ID: 28165461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Partial androgen insensitivity and correlations with the predicted three dimensional structure of the androgen receptor ligand-binding domain.
    Yong EL; Tut TG; Ghadessy FJ; Prins G; Ratnam SS
    Mol Cell Endocrinol; 1998 Feb; 137(1):41-50. PubMed ID: 9607727
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Allosteric conversation in the androgen receptor ligand-binding domain surfaces.
    Grosdidier S; Carbó LR; Buzón V; Brooke G; Nguyen P; Baxter JD; Bevan C; Webb P; Estébanez-Perpiñá E; Fernández-Recio J
    Mol Endocrinol; 2012 Jul; 26(7):1078-90. PubMed ID: 22653923
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Study of novel androgen receptor V770 variant in androgen insensitivity syndrome patients reveals the transitional state of the androgen receptor ligand binding domain homodimer.
    Helsen C; Rocca MS; Nguyen TT; Eerlings R; Lee XY; De Block S; Vinanzi C; Di Millo F; Giagulli V; Voet A; Ferlin A; Claessens F
    Protein Sci; 2023 Apr; 32(4):e4599. PubMed ID: 36806291
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Probing the functional link between androgen receptor coactivator and ligand-binding sites in prostate cancer and androgen insensitivity.
    He B; Gampe RT; Hnat AT; Faggart JL; Minges JT; French FS; Wilson EM
    J Biol Chem; 2006 Mar; 281(10):6648-63. PubMed ID: 16365032
    [TBL] [Abstract][Full Text] [Related]  

  • 6. An examination of how different mutations at arginine 855 of the androgen receptor result in different androgen insensitivity phenotypes.
    Elhaji YA; Wu JH; Gottlieb B; Beitel LK; Alvarado C; Batist G; Trifiro MA
    Mol Endocrinol; 2004 Aug; 18(8):1876-86. PubMed ID: 15118070
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Selectively targeting the dimerization interface of human androgen receptor with small-molecules to treat castration-resistant prostate cancer.
    Dalal K; Ban F; Li H; Morin H; Roshan-Moniri M; Tam KJ; Shepherd A; Sharma A; Peacock J; Carlson ML; LeBlanc E; Perez C; Duong F; Ong CJ; Rennie PS; Cherkasov A
    Cancer Lett; 2018 Nov; 437():35-43. PubMed ID: 30165195
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Human androgen receptor gene ligand-binding-domain mutations leading to disrupted interaction between the N- and C-terminal domains.
    Jääskeläinen J; Deeb A; Schwabe JW; Mongan NP; Martin H; Hughes IA
    J Mol Endocrinol; 2006 Apr; 36(2):361-8. PubMed ID: 16595706
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Evidence for DNA-binding domain--ligand-binding domain communications in the androgen receptor.
    Helsen C; Dubois V; Verfaillie A; Young J; Trekels M; Vancraenenbroeck R; De Maeyer M; Claessens F
    Mol Cell Biol; 2012 Aug; 32(15):3033-43. PubMed ID: 22645304
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The use of androgen receptor amino/carboxyl-terminal interaction assays to investigate androgen receptor gene mutations in subjects with varying degrees of androgen insensitivity.
    Ghali SA; Gottlieb B; Lumbroso R; Beitel LK; Elhaji Y; Wu J; Pinsky L; Trifiro MA
    J Clin Endocrinol Metab; 2003 May; 88(5):2185-93. PubMed ID: 12727974
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Discovery of Novel Androgen Receptor Ligands by Structure-based Virtual Screening and Bioassays.
    Zhou W; Duan M; Fu W; Pang J; Tang Q; Sun H; Xu L; Chang S; Li D; Hou T
    Genomics Proteomics Bioinformatics; 2018 Dec; 16(6):416-427. PubMed ID: 30639122
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Ligand induced dissociation of the AR homodimer precedes AR monomer translocation to the nucleus.
    Shizu R; Yokobori K; Perera L; Pedersen L; Negishi M
    Sci Rep; 2019 Nov; 9(1):16734. PubMed ID: 31723170
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Impaired helix 12 dynamics due to proline 892 substitutions in the androgen receptor are associated with complete androgen insensitivity.
    Elhaji YA; Stoica I; Dennis S; Purisima EO; Lumbroso R; Beitel LK; Trifiro MA
    Hum Mol Genet; 2006 Mar; 15(6):921-31. PubMed ID: 16449235
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Transient, ligand-dependent arrest of the androgen receptor in subnuclear foci alters phosphorylation and coactivator interactions.
    Black BE; Vitto MJ; Gioeli D; Spencer A; Afshar N; Conaway MR; Weber MJ; Paschal BM
    Mol Endocrinol; 2004 Apr; 18(4):834-50. PubMed ID: 14684849
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Androgen receptor mutations identified in prostate cancer and androgen insensitivity syndrome display aberrant ART-27 coactivator function.
    Li W; Cavasotto CN; Cardozo T; Ha S; Dang T; Taneja SS; Logan SK; Garabedian MJ
    Mol Endocrinol; 2005 Sep; 19(9):2273-82. PubMed ID: 15919721
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular basis of androgen insensitivity.
    Brinkmann AO
    Mol Cell Endocrinol; 2001 Jun; 179(1-2):105-9. PubMed ID: 11420135
    [TBL] [Abstract][Full Text] [Related]  

  • 17. A novel mutation in the human androgen receptor suggests a regulatory role for the hinge region in amino-terminal and carboxy-terminal interactions.
    Deeb A; Jääskeläinen J; Dattani M; Whitaker HC; Costigan C; Hughes IA
    J Clin Endocrinol Metab; 2008 Oct; 93(10):3691-6. PubMed ID: 18697867
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Disrupted amino- and carboxyl-terminal interactions of the androgen receptor are linked to androgen insensitivity.
    Thompson J; Saatcioglu F; Jänne OA; Palvimo JJ
    Mol Endocrinol; 2001 Jun; 15(6):923-35. PubMed ID: 11376111
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A new mutation of the androgen receptor, P817A, causing partial androgen insensitivity syndrome: in vitro and structural analysis.
    Lumbroso S; Wagschal A; Bourguet W; Georget V; Mazen I; Servant N; Audran F; Sultan C; Auzou G
    J Mol Endocrinol; 2004 Jun; 32(3):679-87. PubMed ID: 15171708
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro functional characterization of androgen receptor gene mutations at arginine p.856 of the ligand-binding-domain associated with androgen insensitivity syndrome.
    Tajouri A; Kharrat M; Trabelsi M; M'rad R; Hiort O; Werner R
    J Steroid Biochem Mol Biol; 2021 Apr; 208():105834. PubMed ID: 33548461
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.